Company Overview
- Website
- avistatx.com
- Employees
- 9
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$3B
Recent News & Media
Revolutionizing intravitreal gene therapy: Integrating machine learning-guided design of high-complexity AAV capsid libraries with the scAAVengr-HUnT platform | IOVS | ARVO Journals
- Jul 2, 2025
- iovs.arvojournals.org
Avista Therapeutics Presents In Vivo Data for its AAV Capsid in Inherited Retinal Diseases at Association for Research in Vision and Ophthalmology 2025 Annual Meeting
- May 8, 2025
- prnewswire.com
Avista Therapeutics Announces Oral Presentation at Association for Research in Vision and Ophthalmology 2025 Annual Meeting
- Apr 30, 2025
- prnewswire.com
Avista Therapeutics Appoints Steven Altschuler, MD, as Chairman of the Board of Directors
- Jan 7, 2025
- prnewswire.com
Roche expands Dyno gene therapy collab, bets up to $1B-plus that AI can help design better delivery tools
- Oct 24, 2024
- fiercebiotech.com
Avista Therapeutics
- Jun 30, 2024
- thepharmaletter.com
Who is Avista Therapeutics
Avista Therapeutics is a privately held company based in Pittsburgh, Pennsylvania. The company employs 9 people and generates $2.5 million in annual revenue. Avista Therapeutics focuses on developing innovative gene therapies for retinal diseases, particularly rare, inherited conditions that significantly impact patients' quality of life. Their therapies aim to address challenges in gene therapy delivery, including cell-type specific targeting, reduced dosages, and efficient expression, using a minimally invasive intravitreal approach. The company leverages its computationally guided scAAVengr platform to generate and validate a proprietary toolkit of AAV vectors. Avista's quantitative, in vivo-based approach and clinical ophthalmology expertise enable rapid translation of new gene therapies into clinical trials. Avista Therapeutics can be reached via their website at avistatx.com.
Avista Therapeutics Industry Tags
Companies Similar to Avista Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Avista Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | 2 | Cambridge, MA | 2005 | |
| 3M | 7 | New York, NY | 2008 | |
| 3M | 3 | New York, NY | ||
| 3M | 2 | Knoxville, TN | 2004 | |
| 3M | 35 | Austin, TX |